Pages that link to "Q44536202"
Jump to navigation
Jump to search
The following pages link to Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia (Q44536202):
Displaying 50 items.
- GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche (Q24318334) (← links)
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression (Q24635943) (← links)
- Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents (Q24798873) (← links)
- Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence (Q26770388) (← links)
- Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim (Q27322913) (← links)
- Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities (Q28071384) (← links)
- Bone marrow stromal cells protect lymphoma B‐cells from rituximab‐induced apoptosis and targeting integrin α‐4‐β‐1 (VLA‐4) with natalizumab can overcome this resistance (Q28243054) (← links)
- Survival regulation of leukemia stem cells (Q28271278) (← links)
- Targeting leukocyte integrins in human diseases (Q28293910) (← links)
- Ligand bound beta1 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells (Q28469144) (← links)
- The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia (Q28479144) (← links)
- Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis (Q28483881) (← links)
- MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism (Q28658170) (← links)
- The difficulty of targeting cancer stem cell niches (Q28744461) (← links)
- Translating leukemia stem cells into the clinical setting: Harmonizing the heterogeneity (Q30244186) (← links)
- Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia. (Q30588887) (← links)
- Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging (Q33246431) (← links)
- Leukemia-targeting ligands isolated from phage-display peptide libraries. (Q33270272) (← links)
- Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia (Q33493174) (← links)
- Molecular deconstruction, detection, and computational prediction of microenvironment-modulated cellular responses to cancer therapeutics (Q33605227) (← links)
- The Role of PI3K Isoforms in Regulating Bone Marrow Microenvironment Signaling Focusing on Acute Myeloid Leukemia and Multiple Myeloma. (Q33607950) (← links)
- The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia (Q33655756) (← links)
- Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia (Q33852603) (← links)
- High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group (Q33990843) (← links)
- The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. (Q34024558) (← links)
- Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells (Q34045687) (← links)
- Identification of Hepatic Niche Harboring Human Acute Lymphoblastic Leukemic Cells via the SDF-1/CXCR4 Axis (Q34070556) (← links)
- Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? (Q34103451) (← links)
- Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors (Q34152009) (← links)
- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. (Q34260622) (← links)
- Induction of hypoxia-inducible factor-1α inhibits drug-induced apoptosis in the human leukemic cell line HL-60. (Q34316938) (← links)
- Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies (Q34367804) (← links)
- Of microenvironments and mammary stem cells (Q34418850) (← links)
- CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells (Q34440437) (← links)
- Activation of the vascular niche supports leukemic progression and resistance to chemotherapy (Q34622824) (← links)
- Leukemia Mediated Endothelial Cell Activation Modulates Leukemia Cell Susceptibility to Chemotherapy through a Positive Feedback Loop Mechanism (Q34656484) (← links)
- New strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine (Q34715598) (← links)
- The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents. (Q34992255) (← links)
- Contribution of bone microenvironment to leukemogenesis and leukemia progression (Q35037058) (← links)
- Real-time analysis of the inside-out regulation of lymphocyte function-associated antigen-1 revealed similarities to and differences from very late antigen-4. (Q35063491) (← links)
- Right on target: eradicating leukemic stem cells (Q35132225) (← links)
- Functional and structural insights into ASB2alpha, a novel regulator of integrin-dependent adhesion of hematopoietic cells (Q35182907) (← links)
- Halogenated benzimidazole carboxamides target integrin alpha4beta1 on T-cell and B-cell lymphomas (Q35194110) (← links)
- High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse (Q35528643) (← links)
- Homing of cancer cells to the bone (Q35603135) (← links)
- Osteoblastic and vascular endothelial niches, their control on normal hematopoietic stem cells, and their consequences on the development of leukemia (Q35608638) (← links)
- Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype (Q35612803) (← links)
- Development and molecular characterization of polymeric micro-nanofibrous scaffold of a defined 3-D niche for in vitro chemosensitivity analysis against acute myeloid leukemia cells (Q35633299) (← links)
- Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration (Q35669055) (← links)
- Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase (Q35677647) (← links)